These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28371390)

  • 1. Video-assisted thoracoscopy in the management of intrapleural extravasation of cytotoxic chemotherapy.
    Aguirre VJ; Barnett D; Burdett N; Joshi R; Viana FF
    Thorac Cancer; 2017 Jul; 8(4):363-364. PubMed ID: 28371390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful experience utilizing dexrazoxane treatment for an anthracycline extravasation.
    Tyson AM; Gay WE
    Ann Pharmacother; 2010 May; 44(5):922-5. PubMed ID: 20371757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane: an overview and outcomes.
    Caballero Romero Á; Delgado Ureña MT; Salmerón García A; Megías Fernández MT; Librada Porriño-Bustamante M; Cabeza Barrera J
    Anticancer Drugs; 2018 Oct; 29(9):821-826. PubMed ID: 30036190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BET 3: emergency management of anthracycline extravasation.
    Drake D
    Emerg Med J; 2012 Sep; 29(9):777-9. PubMed ID: 22903427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed presentation of doxorubicin extravasation into pleural space: Case report and review of literature.
    Kazakova V; Vanegas YAM; Torres TA; Kozyreva O
    J Oncol Pharm Pract; 2021 Sep; 27(6):1520-1527. PubMed ID: 33241731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature.
    Aigner B; Bauernhofer T; Petru E; Niederkorn A; Arzberger EJ; Richtig E
    Dermatology; 2014; 229(4):288-92. PubMed ID: 25472626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapleural extravasation of epirubicin, 5-fluouracil, and cyclophosphamide, treated with dexrazoxane.
    Uges JW; Vollaard AM; Wilms EB; Brouwer RE
    Int J Clin Oncol; 2006 Dec; 11(6):467-70. PubMed ID: 17180516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine experimental anthracycline extravasation model: pathology and study of the involvement of topoisomerase II alpha and iron in the mechanism of tissue damage.
    Thougaard AV; Langer SW; Hainau B; Grauslund M; Juhl BR; Jensen PB; Sehested M
    Toxicology; 2010 Feb; 269(1):67-72. PubMed ID: 20079798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexrazoxane for anthracycline extravasation and GM-CSF for skin ulceration and wound healing.
    El-Saghir N; Otrock Z; Mufarrij A; Abou-Mourad Y; Salem Z; Shamseddine A; Abbas J
    Lancet Oncol; 2004 May; 5(5):320-1. PubMed ID: 15120669
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of anthracycline extravasation with dexrazoxane.
    Langer SW; Sehested M; Jensen PB
    Clin Cancer Res; 2000 Sep; 6(9):3680-6. PubMed ID: 10999761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful management of doxorubicin overdose and extravasation in a dog with lymphoma.
    Kicenuik KS; Northrup NC; Clarke DM; Bazzle LJ
    Can Vet J; 2018 Oct; 59(10):1079-1084. PubMed ID: 30510312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexrazoxane: a management option for anthracycline extravasations.
    Vidall C; Roe H; Dougherty L; Harrold K
    Br J Nurs; 2013 Sep 12-25; 22(17):S6 -12. PubMed ID: 24067273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.
    Conde-Estévez D; Saumell S; Salar A; Mateu-de Antonio J
    Anticancer Drugs; 2010 Sep; 21(8):790-4. PubMed ID: 20671512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of anthracycline extravasation with dexrazoxane -- clinical experience.
    Frost A; Gmehling D; Azemar M; Unger C; Mross K
    Onkologie; 2006 Jul; 29(7):314-8. PubMed ID: 16874015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexrazoxane treatment of doxorubicin extravasation injury in four dogs.
    Venable RO; Saba CF; Endicott MM; Northrup NC
    J Am Vet Med Assoc; 2012 Feb; 240(3):304-7. PubMed ID: 22256846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of dexrazoxane for the prevention of anthracycline extravasation injury.
    Hasinoff BB
    Expert Opin Investig Drugs; 2008 Feb; 17(2):217-23. PubMed ID: 18230055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexrazoxane use in the prevention of anthracycline extravasation injury.
    Hasinoff BB
    Future Oncol; 2006 Feb; 2(1):15-20. PubMed ID: 16556068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of anthracycline extravasations using dexrazoxane.
    Conde-Estévez D; Mateu-de Antonio J
    Clin Transl Oncol; 2014 Jan; 16(1):11-7. PubMed ID: 23949792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice.
    Langer SW; Sehested M; Jensen PB
    Ann Oncol; 2001 Mar; 12(3):405-10. PubMed ID: 11332155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival.
    Tahover E; Segal A; Isacson R; Rosengarten O; Grenader T; Gips M; Cherny N; Heching NI; Mesika L; Catane R; Gabizon A
    Anticancer Drugs; 2017 Aug; 28(7):787-794. PubMed ID: 28562379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.